Cohort studies | Aftab et al (2017) [22] | Kishore et al (1971) | Gupta et al (2018) [21] | Oluboyo et al (1990) [18] | Basoglu et al(1999) [20] | Singh et al (1984) [17] | Boillat et al (2016) | Yan Lin et al (2017) [23] | Kornfeld et al, (2016) [19] | Kubjane et al (South Africa, 2019) | Philips et al (South Africa 2017) [24] |
---|---|---|---|---|---|---|---|---|---|---|---|
Selection (maximum 4 points) | |||||||||||
 Representativeness of the exposed cohort | * |  | * | * | * | * |  | * | * | * | * |
 Selection of the non-exposed cohort? |  |  |  |  |  |  |  |  |  | * |  |
 Ascertainment of exposure | * |  | * | * | * | * |  | * | * | * | * |
 Demonstration that outcome of interest was not present at start of study | * |  | * | * | * | * |  | * | * | * | * |
Comparability (maximum 2 points) | |||||||||||
 Comparability of cohorts on the basis of the design or analysis |  |  |  | * | * |  |  | * | * | * | * |
 Study controls for at least 3 additional risk factors? |  |  |  |  |  |  |  | * | * | * |  |
Exposure (maximum 3) | |||||||||||
 Assessment of outcome/Assessment of outcome Independent blind assessment, record linkage | * |  | * | * | * | * |  | * | * | * | * |
 Was follow-up long enough for outcomes to occur? | * |  | * | * | * | * |  | * | * | * | * |
 Loss to follow up of NDM cohort < 10% or unclear | * |  | * | * |  | * |  | * |  | * | * |
Total score: 9 | 6 | Â | 6 | 7 | 6 | 6 | Â | 8 | 7 | 9 | 7 |
Case control studies | |||||||||||
Selection of cases and controls (maximum 4 points) | |||||||||||
 Case definition adequate |  | * |  |  |  |  | * |  |  |  |  |
 Representativeness of the cases |  | * |  |  |  |  | * |  |  |  |  |
 Selection of controls |  | * |  |  |  |  | * |  |  |  |  |
 Definition of control |  | * |  |  |  |  | * |  |  |  |  |
Comparability (maximum 2) | |||||||||||
 Comparability of cases and controls on the basis of the design or analysis |  | * |  |  |  |  | * |  |  |  |  |
Study controls for at least 3 additional risk factors | |||||||||||
Exposure (maximum 3) | |||||||||||
 Ascertainment of exposure |  | * |  |  |  |  | * |  |  |  |  |
 Same method cases and controls |  | * |  |  |  |  | * |  |  |  |  |
 Non-response rate < 10% or unclear |  | * |  |  |  |  | * |  |  |  |  |
Total (maximum 8) | Â | 8 | Â | Â | Â | Â | 8 | Â | Â | Â | Â |